INTRODUCTION
Anti-VEGF drugs, specifically bevacizumab (Avastin; Genentech, South San Francisco, CA), have been successfully employed alone [1] [2] [3] [4] or in combination with other therapeutic agents [5] [6] [7] to treat retinopathy of prematurity (ROP).
Optical coherence tomography (OCT), a noninvasive technique that enables cross-sectional retinal imaging, and more recently, high-resolution spectraldomain optical coherence tomography (SD-OCT) have been used to study the macula in patients with ROP. [8] [9] [10] [11] [12] [13] [14] [15] Significant advances have been made in the use of SD-OCT, namely in the understanding of central retinal development and anatomy. 16, 17 In the preterm infant population, the use of this technique imposes additional challenges. Adequate testing techniques and devices must be made available. 18, 19 More importantly, distinguishing normal retinal developmental changes 20 from those arising from pathologies or therapeutic interventions remains a key goal.
Current ROP management techniques yield healthy-looking and vascularized retinas in individuals with ROP. The present goal is to detect the factors that are responsible for achieving good vision in these eyes. The identification of fine retinal characteristics using SD-OCT may play a key role in achieving this goal. The identification of prognostic factors will also aid in the selection of treatment options.
This study reports the results of our work using SD-OCT to study the macula in preterm infants treated with Avastin for ROP.
PATIENTS AND METHODS
Twenty eyes of 11 patients who were treated with Avastin for ROP between 2007 and 2011 were included in the study. Most of the patients had been treated for type 1 ROP with a single intravitreal injection of Avastin. Other premature patients were referred due to progression of the disease despite laser treatment or due to stage 4A ROP requiring further treatment that included Avastin and/or vitreoretinal surgery.
The use of bevacizumab in our patients with ROP was discussed and approved by members of the National Neonatal Network. In all cases, written informed consent was obtained from the patients' guardians before injections were administered.
Imaging was performed under sedation during routine follow-up examinations with a portable SD-OCT device (iVue with iStand; Optovue, Fremont, CA). This Optovue OCT does not have approval from the U.S. Food and Drug Administration. For the purposes of this study, images obtained with this device were comparable to others we have obtained with a newer SD-OCT, the Envisu 2300 (Bioptigen; Research Triangle Park, NC). In our experience, the Bioptigen OCT expands the potentials of pediatric OCT and also has FDA approval.
Both eyes of all infants were dilated by the instillation of one drop of phenylephrine hydrochloride 2.5% and tropicamide 1%. Following pupillary dilation, a clinical examination, including indirect ophthalmoscopy with a 28 D lens, was performed. After acquiring the OCT images, a series of retinal photographs were obtained using the RetCam imaging system (Clarity Medical Systems, Pleasanton, CA). All images were obtained by one of the authors.
Images from 20 eyes of 10 non-premature children with a mean age of 9 years (range: 5 to 16 years) with normal ophthalmoscopic findings and 20/20 vision were also examined.
All of the SD-OCT images were analyzed with the integrated software provided in the iVue system, and the following macular measurements were performed: presence of foveal contour (FC), retina map, central foveal thickness (CFT), parafoveal thickness (PT), and perifoveal thickness (PPT). The total, inner retinal (IRL), and outer retinal (ORL) layers were studied. A foveal-parafoveal index (F/P index) was calculated to quantify the foveal depth by dividing the CFT by the PT (the lower the value, the deeper the foveal pit). The following retinal layer measurements were performed for all images: nerve fiber layer (NFL), ganglion cell layer (GCL), inner nuclear layer (INL), outer plexiform layer (OPL), outer nuclear layer (ONL), external limiting membrane (ELM), inner to outer segment (IS/OS), outer segment to retinal pigment epithelium (OS/RPE), and RPE. The OCT images were further analyzed using cross-line and three-dimensional reconstructions for foveal devel- opmental signs and foveal avascular zone characteristics.
RESULTS
Twelve eyes of seven patients were treated with a single intravitreal injection of Avastin for type 1 ROP. Five eyes of four patients received Avastin after laser treatment, and three eyes of two patients underwent micro-incision vitrectomy for stage 4A retinal detachments. The outcome after treatment was favorable in all eyes.
The mean gestational age was 25 weeks, the mean birth weight was 722.5 g, and the mean chronological age at the time of OCT was 28.9 months (range: 4 to 50 months) ( Table 1) .
Fundus examination in all patients using indirect ophthalmoscopy and RetCam images revealed an unexceptional-looking posterior pole and macula to our routine examiners. A more detailed review of the RetCam images by more expert readers revealed the presence of some macular changes, especially related to foveal reflex characteristics, but none were exclusive nor directly correlated with one particular underlying retinal structure. The SD-OCT images taken in each case were the only way of determining the macular architecture in these infants. Additionally, one patient exhibited a small decrease in the temporal vascular arcade angle and three eyes showed pallor of the optic disc at the time of treatment. Table 2 depicts the measurements of the retinal areas in different groups of patients according to their retinal configuration. Of the 20 eyes treated with Avastin for ROP, the mean CFT was 245.1 ± 31.8 µm, and the mean PT was 262.7 ± 38.4 µm, with an F/P index of 0.94 ± 0.07. Thirteen eyes (of seven patients) of the 20 eyes (65%) developed an FC (foveal pit) with a mean CFT of 253.8 ± 23.2 µm, PF of 280.8 ± 27 µm, and F/P index of 0.9 ± 0.1. Of these eyes, 46% had zone I ROP. Seven eyes (35%) of four patients did not develop an FC. In this group, the mean CF was 228.86 ± 38.4 µm, and the mean PT was 229.14 ± 33.46 µm, resulting in an F/P index of 1.0 ± 0.04. All of these eyes had zone I ROP. The presence (or absence) of an FC was bilateral.
In the group of non-premature children, an FC was noted in all cases. These patients presented a mean CF of 245.4 ± 15.3 µm, PT of 307.9 ± 11.1 µm, and F/P index of 0.79 ± 0.03.
Compared with non-premature children, the group of treated patients with FC development showed an increased CFT, a reduced PT and PPT, and a shallow foveal pit (mean F/P index: 0.9 vs 0.79). The thickness reduction in the PT and PPT in these patients was due to a thinner IRL at those points. The thickness of the ORL at the fovea, parafovea, and perifovea does not differ from these measurements in non-premature children. A higher F/P index was explained by an increase in the CFT (secondary to the presence of an IRL at the fovea) and a thinner IRL at the parafovea and perifovea ( Table 2) .
The morphological analysis of the retina in the group of treated patients with an FC showed that all retinal layers were present at the macula with persistence of retinal layers over the fovea (INL and IPL). The following signs of macular development were also noted: OS elongation, IS/OS and external limiting membrane presence, and thickening of the ONL at the fovea (Figure 1) .
Patients without FC development (ie, with no foveal pit) presented a mean F/P index of 1. These patients showed a reduced CFT, PT, and PPT compared with treated ROP patients with FC development and with non-premature children ( Table 2 ). The retinal thickness reduction at all three points was due to a 
CFT = central foveal thickness; PT = parafoveal thickness; PPT = perifoveal thickness; F/P index = fovealparafoveal index; IFT = internal foveal thickness; IPT = internal parafoveal thickness; IPPT = internal perifoveal thickness; OFT = outer foveal thickness; OPT = outer parafoveal thickness; OPPT = outer perifoveal thickness.
thinner ORL and IRL. The greatest thickness reduction was in the IRL at the PT and PPT. Image analysis of these patients revealed that although there was retinal layer persistence, not all retinal layers were present. The FL was absent except in patients with good visual acuity, and differentiation between the GCL and IPL was difficult. The following signs of macular development were also noted: OS elongation, the presence of the IS/ OS and external limiting membrane, and thickening of the ONL. These morphological characteristics enable the recognition of the foveal area in the absence of a foveal pit (Figure 2) .
The absence of FC development was associated with a lower gestational age and zone I disease. Preterm infants with no foveal pit were all zone I cases and had a mean gestational age of 24.5 weeks. Patients with a foveal pit had a mean gestational age of 25.6 weeks (25 weeks when the disease was located in zone I and 26 weeks when located in zone II) (Table 3) . When an FC was present, vision tended to be better. In patients without an FC, two of the five eyes with measurable VA had better than 20/400 vision compared with 10 of 11 eyes with an FC (Table 3) .
Morphological analysis of the retina in the group of patients with no FC revealed differences between patients with good vision and those with poor vision. In the two eyes with good VA, the foveal site Example of a case with foveal contour development (13 eyes in seven patients). OCT and RetCam (Clarity Medical Systems, Pleasanton, CA) images of the left eye of patient 5 at 28 months after Avastin (bevacizumab; Genentech, South San Francisco, CA) treatment (birth weight: 720 g; gestational age: 24 weeks; zone I ROP). All retinal layers were present. Persistence of retinal layers (inner nuclear, inner plexiform) over the fovea (red bracket). Signs of macular development: outer segment elongation, inner segment/outer segment and external limiting membrane presence (blue arrows), and thickening of the outer nuclear layer at the fovea (orange bracket).
revealed the persistence of distinct retinal layers, maturation signs, a reduced or nonexistent FAZ, and a CFT that was maintained compared with that of treated preterm infants with FC development. In eyes that presented with poor visual acuity, the foveal location could also be identified using signs of maturation. There were persistent retinal layers present, but these IRLs could not be clearly identified. FAZ was reduced or nonexistent and the CFT was decreased compared with treated preterm infants with FC development (Figure 3 ).
DISCUSSION
This study shows that the use of Avastin for the treatment of advanced ROP can result in different macular configurations, as revealed by SD-OCT. Despite a normal-looking retinal fundus in ophthalmoscopy and RetCam images, two distinct macular configurations showing the presence or absence of an FC could be observed in these patients.
Patients with FC development represented 65% of the eyes in our study. An increased CFT and a shallow foveal pit (evidenced by a higher F/P index) were observed in preterm infants. The failure of the migration of the inner retinal layers explains this increased central foveal thickness. Previous reports have also shown this condition 13, [21] [22] [23] in preterm infants who did not receive Avastin. In this study, the thickness measurements of the ORL at the fovea, parafovea, and perifovea in preterm children do not differ from those in non-premature children.
In the group of patients treated with Avastin who did not develop an FC, the presence of foveal maturation signs 14 allowed for the location of the macula. The absence of the foveal pit was accompanied by a decrease in the retinal thickness at all measured points, and the layer analysis notably showed that not all of the retinal layers were present.
The absence of an FC was encountered in the smallest preterm infants, and all were zone I cases. An explanation for this result could be that changes secondary to ROP in a very immature retina can stop foveal pit development. There is evidence to suggest that it is not due to the Avastin. These features and associations were seen in the absence of Avastin in previous studies. 13, 20, 22 In this study, the absence of an FC appears to correlate with poor vision. While two of the five eyes with measurable VA had better than 20/400 vision when the foveal pit was absent, 10 of the 11 eyes with a foveal pit had better than 20/400 VA. The term "fovea plana" has been used to identify retinas without a foveal pit. 24 An absent foveal depression had previously not been shown to negatively influence visual function. 8, 24 Although the majority of eyes without an FC in this study had poor vision, a distinct retinal anatomy could be observed in the eyes that presented with good vision without an FC; specifically, the foveal site revealed the persistence of distinct retinal layers, maturation signs, a reduced or nonexistent FAZ, and a maintained CFT.
The clinical identification of this particular retinal configuration using SD-OCT may be predictive of better visual acuity.
Current ROP management techniques allow for healthy-looking and possibly fully vascularized retinas for individuals with ROP. The current goal of ophthalmologists is to identify the factors that are responsible for achieving good vision in the presence of ROP. Identification of these factors will thus inform therapeutic decisions, and SD-OCT studies may play a key role in this process.
